Table 1

Global precision medicine initiatives of relevance to type 2 diabetes

NameRegionStart dateFundingInitiativePopulation (in thousands)
Australian Precision Medicine InitiativeAustralia2016A$25 millionPublic–private
Chinese Precision Medicine InitiativeChina2016US$9 billionPublic–private2
Innovative Medicines Initiative (diabetes projects only)European Union2008€200 millionPublic–private>100
Nordic Precision Medicine InitiativeNordic (Denmark, Estonia, Finland, Iceland, Norway, and Sweden)2015Public–private>1,000
Estonian Personalised Medicine Pilot Project (Nordic Precision Medicine Initiative)Nordic (Estonia)2015€33 millionGovernmental100
FinnGen (Nordic Precision Medicine Initiative)Nordic (Finland)2017€60 millionPublic–private500
Genomic Aggregation Project in Sweden (Nordic Precision Medicine Initiative)Nordic (Sweden)2015Public160
Saudi Human Genome ProjectSaudi Arabia2013US$40 millionGovernmental100
Genomics EnglandU.K.2012US$523 millionPublic–private75
UK BiobankU.K.2005US$122 millionPublic–private500
Project BaselineU.S.2017>US$41 millionPublic–private10
U.S. Precision Medicine InitiativeU.S.2015US$215 millionPublic–private1,000
Accelerating Medicines PartnershipU.S.2014US$52.8 millionPublic–private150
Million Veteran ProgramU.S.2011US$116 millionPublic–private612